Given the complex divergent nature of IL-1 family members across many pathologies including cancers, it is of little surprise that IL-36R signalling may indeed have both pro- and anti- tumorigenic effects, especially in a complex disease such as CRC. Here, IL1RL2 is linked to cancer.